nejm semaglutide ckd ✍️✓🆕A pathbreaking trial published in @NEJM today 👍FLOW Trial 💉in Diabetic 🫡Significant benefits in renal and cardiovascular outcomes @ERAkidney #ERA24 @NEJM ❇️Patients with obesity, type 2
Description
20251222(FDA)(GLP-1)Novo NordiskWegovy
The study finds that semaglutide 2.4 mg, when used consistently, is a cost-effective and clinically valuable treatment for obesity in Japan, reducing obesity-related complications and improving quality of life.
Louisville, KY
GLP-1s like Ozempic, Wegovy, and Mounjaro have gained a lot of media attention for weight loss, but how do these weight-loss injections work
Ozempic for managing type 2 diabetes and weight loss
Struggling to get a GLP-1 prescription covered
